(Q43504139)

24 November 2017

Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells (English)

1 reference

24 November 2017

0 references

1 reference

Zhang J

1

1 reference

24 November 2017

Ren S

series ordinal

2

1 reference

24 November 2017

Shen GX

series ordinal

3

1 reference

24 November 2017

language of work or name

1 reference

1 June 2000

1 reference

24 November 2017

1 reference

24 November 2017

150

1 reference

24 November 2017

2

1 reference

24 November 2017

299-308

1 reference

Lp(a) lipoprotein: an overview

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

A potential basis for the thrombotic risks associated with lipoprotein(a).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Plasminogen activator inhibitor-1 expression by brain microvessel endothelial cells is inhibited by elevated glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Plasminogen Activator Inhibitor Type-1 Synthesis and mRNA Expression in HepG2 Cells Are Regulated by VLDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Sequential flotation ultracentrifugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

G proteins and phospholipase C mediate thrombin-induced generation of plasminogen activator inhibitor-1 from vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoprotein(a) concentration in diabetes: relationship to proteinuria and diabetes control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Serum lipoprotein(a) in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoprotein(a) in type 1 diabetic patients with renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoprotein (a) and vascular disease in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoprotein(a) in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lp(a) concentrations and phenotypes in children with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoprotein(a) is a risk factor for diabetic retinopathy in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoprotein(a) is an independent risk factor for multiple cerebral infarctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Effect of insulin treatment on serum lipoprotein(a) in non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Advanced glycation end-products and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

[Lipoprotein(a) as a risk factor for cardiovascular disease in elderly patients with diabetes].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900381-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(99)00381-0

1 reference

24 November 2017

1 reference